Donazioni 15 September, 2024 – 1 Ottobre, 2024 Sulla raccolta fondi

In Sight: My Life in Science and Biotech

Main
In Sight: My Life in Science and...

In Sight: My Life in Science and Biotech

Julia Levy

0 / 4.0

Quanto ti piace questo libro?

Qual è la qualità del file?

Scarica il libro per la valutazione della qualità

Qual è la qualità dei file scaricati?

Covering issues within the scientific community, In Sight is a deeply personal memoir of a woman's experience transitioning a major scientific treatment from grassroots development to commercial breakthrough.

Anno:

2020

Casa editrice:

University of Toronto Press

Lingua:

english

ISBN 10:

148750831X

ISBN 13:

9781487508319

File:

EPUB, 6.52 MB

IPFS:

,

english, 2020

Leggi Online

La conversione in è in corso

La conversione in non è riuscita

Puoi essere interessati a

Ronald Evens — Drug and Biological Development: From Molecule to Product and Beyond

Critser, Greg — Generation Rx: how prescription drugs are transforming American lives, minds, and bodies

Alicia Loffler — Kellogg on Biotechnology : Thriving through Integration (Kellogg)

DAVID CAVAIIA — OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

WetFeet — The WetFeet Insider Guide to Careers in Biotech and Pharmaceuticals

WetFeet — Careers in Biotech & Pharmaceuticals: The WetFeet Insider Guide (2005 Edition)

Decision Resources Inc — The SAGE Handbook of Healthcare (Sage Handbooks)

S. Riley — The Future of Monoclonal Antibody Therapeutics

Thomas J. Dougherty — The circuitous route by a group of novices to a new FDA approved cancer therapy

Desconocido — 27. BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT PROCESS (INGLES) AUTOR PHRMA

Regulatory Affairs Professionals Society. — Fundamentals of Pharmaceutical and Biologics Regulations Volume I

Rao A.K., Moussalli C. — Vault Career Guide to Biotech

— The Cancer Market Outlook to

Ibis Sanchez-Serrano — The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside

Tamas Bartfai and Graham V. Lees (Auth.) — The Future of Drug Discovery. Who Decides Which Diseases to Treat?

United States — Office of Technology Assessment. Pharmaceutical R And D: Costs, Risks And Rewards

Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos — From Breakthrough to Blockbuster

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Alan Morrison — Biotechnology Law: A Primer for Scientists

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Morrison, Alan — Biotechnology Law: A Primer for Scientists

Committee on Accelerating Rare Diseases Research and Orphan Product Development, Institute of Medicine — Rare Diseases and Orphan Products: Accelerating Research and Development

Marcia Angell — The Truth About the Drug Companies: How They Deceive Us and What to Do About It

Clinical Professor Ronald P. Evens Pharm D., FCCP (auth.), Clinical Professor Ronald P. Evens Pharm D., FCCP (eds.) — Drug and Biological Development: From Molecule to Product and Beyond

John L. LaMattina — Drug Truths: Dispelling the Myths About Pharma R & D

Shreefal S. Mehta — Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices

Zenios, Stefanos — Biodesign the process of innovating medical technologies

John Griffin, John O'Grady — Regulation of Medical Products

Sheller, Stephen; Kirkpatrick, Sidney — Pharmageddon A Nation Betrayed

Thomas M. Jacobsen, Albert I. Wertheimer — Modern Pharmaceutical Industry: A Primer

Fred C. Pampel — Prescription Drugs

Henry I. Miller — To America's Health: A Proposal to Reform the Food and Drug Administration

Tingting Qiu, Mondher Toumi — Regenerative Medicine: Unlocking Patient Access and Commercial Potential

Lawton Robert Burns (editor) — The Business of Healthcare Innovation

Lawton Robert Burns — The Business of Healthcare Innovation

Termini più frequenti